The European Commission (EC) has approved Novartis’ Enerzair Breezhaler (indacaterol acetate, glycopyrronium bromide and mometasone furoate) for uncontrolled asthma. More specifically, the drug has been cleared as a maintenance treatment […]
As COVID-19 vaccines near final stages of testing, governments are also racing against each other, busy securing supply for their own countries even before key efficacy data readouts. After signing […]
Johnson & Johnson has been on a manufacturing deal spree as it nears human trials for its COVID-19 vaccine hopeful. On the same day it inked a $480 order from […]
Meeting global demand for a potential COVID-19 treatment is more than any one company can handle on its own. Acknowledging that reality, Japanese drugmaker Fujifilm has picked partners for its […]
In 2019, the top 10 pharmaceutical R&D spenders collectively plowed a whopping $82 billion into their search for new drugs, diagnostics and vaccines, around $4 billion more than the previous year. […]
